Package 84324-031-01

Brand: nuvicare hives relief

Generic: fexofenadine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 84324-031-01
Digits Only 8432403101
Product NDC 84324-031
Description

30 TABLET in 1 BOTTLE (84324-031-01)

Marketing

Marketing Status
Marketed Since 2026-01-21
Brand nuvicare hives relief
Generic fexofenadine hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "8a758eab-e855-4cac-85e1-c7df0aa2150d", "openfda": {"unii": ["2S068B75ZU"], "rxcui": ["997420"], "spl_set_id": ["a8e11094-ca69-488d-a720-b8129f17f505"], "manufacturer_name": ["NUVICARE LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (84324-031-01)", "package_ndc": "84324-031-01", "marketing_start_date": "20260121"}], "brand_name": "Nuvicare Hives Relief", "product_id": "84324-031_8a758eab-e855-4cac-85e1-c7df0aa2150d", "dosage_form": "TABLET", "pharm_class": ["Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]"], "product_ndc": "84324-031", "generic_name": "FEXOFENADINE HYDROCHLORIDE", "labeler_name": "NUVICARE LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Nuvicare Hives Relief", "active_ingredients": [{"name": "FEXOFENADINE HYDROCHLORIDE", "strength": "180 mg/1"}], "application_number": "ANDA210137", "marketing_category": "ANDA", "marketing_start_date": "20260121", "listing_expiration_date": "20271231"}